Erkki Ruoslahti Insider Trading $ACTC Ocata Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Erkki Ruoslahti.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Erkki Ruoslahti. Erkki Ruoslahti is Director in Ocata Therapeutics, Inc. ($ACTC).
Erkki Ruoslahti in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Erkki Ruoslahti: Director
Holdings: 2,744,119 shares
Latest Transaction: Mar 08 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Erkki Ruoslahti in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.17 | 100,000 | 16,600 | 2,744,119 | 2.8 M to 2.7 M (-3.52 %) |
| Mar 08 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.17 | 150,000 | 25,050 | 2,844,119 | 3 M to 2.8 M (-5.01 %) |
| Mar 08 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.17 | 250,000 | 41,650 | 2,994,119 | 3.2 M to 3 M (-7.71 %) |
| Mar 07 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.17 | 250,000 | 42,500 | 3,244,119 | 3.5 M to 3.2 M (-7.15 %) |
| Mar 03 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 10,630 | 1,866 | 3,494,119 | 3.5 M to 3.5 M (-0.30 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 250,000 | 43,750 | 3,504,749 | 3.8 M to 3.5 M (-6.66 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 72,050 | 12,609 | 3,754,749 | 3.8 M to 3.8 M (-1.88 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 250,000 | 43,750 | 3,826,799 | 4.1 M to 3.8 M (-6.13 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 107,675 | 18,843 | 4,076,799 | 4.2 M to 4.1 M (-2.57 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 10,000 | 1,760 | 4,184,474 | 4.2 M to 4.2 M (-0.24 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 5,000 | 875 | 4,194,474 | 4.2 M to 4.2 M (-0.12 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 10,000 | 1,769 | 4,199,474 | 4.2 M to 4.2 M (-0.24 %) |
| Mar 01 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 2,876 | 503 | 4,209,474 | 4.2 M to 4.2 M (-0.07 %) |
| Feb 18 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.19 | 150,000 | 28,035 | 4,212,350 | 4.4 M to 4.2 M (-3.44 %) |
| Feb 18 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.19 | 250,000 | 46,325 | 4,362,350 | 4.6 M to 4.4 M (-5.42 %) |
| Feb 15 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.18 | 137,650 | 25,190 | 4,612,350 | 4.8 M to 4.6 M (-2.90 %) |
| Feb 15 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.19 | 173,100 | 32,024 | 4,750,000 | 4.9 M to 4.8 M (-3.52 %) |
| Feb 15 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.19 | 66,900 | 12,443 | 4,923,100 | 5 M to 4.9 M (-1.34 %) |
| Feb 15 2011 | ACTC | Ocata Therapeutics ... | Ruoslahti Erkki | Director | Sell | S | 0.19 | 10,000 | 1,866 | 4,990,000 | 5 M to 5 M (-0.20 %) |
Page: 1